feed,title,long_url,short_url
Benzinga,ObsEva SA Reports Positive Topline Results of the PROLONG Proof-of-Concept Trial of Ebopiprant (OBE022) for Treatment of Preterm Labor,https://www.benzinga.com/pressreleases/20/11/g18376702/obseva-sa-reports-positive-topline-results-of-the-prolong-proof-of-concept-trial-of-ebopiprant-obe,https://j.mp/36Fff9V
